Whan In Pharm Co.,Ltd.

KSE 016580.KS

Whan In Pharm Co.,Ltd. Return on Assets (ROA) for the year ending December 31, 2023: 7.42%

Whan In Pharm Co.,Ltd. Return on Assets (ROA) is 7.42% for the year ending December 31, 2023, a 14.59% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Whan In Pharm Co.,Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was 6.48%, a -14.20% change year over year.
Whan In Pharm Co.,Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 7.55%, a 6.36% change year over year.
Whan In Pharm Co.,Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 7.10%, a 15.73% change year over year.
Whan In Pharm Co.,Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was 6.13%, a -18.02% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

KSE: 016580.KS

Whan In Pharm Co.,Ltd.

CEO	Mr. Wonbum Lee
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Whanin Building, 11
Employees	582
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years